4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Synovitis: new trials by email Literature Review of Synovitis trials Research Report on Synovitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis Fixed Dose Etoricoxib + Betamethasone, Monotherapy Etoricoxib - Bursitis, Tendinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 89 | 2025-05-14 | 2026-01-08 |
| Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) AIN457 (secukinumab), Placebo - Psoriatic Arthritis | Phase 3 | Completed | Novartis Pharmaceuticals | 166 | 2016-08-22 | 2021-12-07 |
| Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) Pexidartinib, Placebo - Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath | Phase 3 | Completed | Daiichi Sankyo | 120 | 2015-05-11 | 2022-05-11 |
| Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee Chondroitin sulphate (Condrosan), Placebo - Synovitis, Osteoarthritis | Phase 3 | Completed | Bioiberica | 70 | 2008-02-01 | 2011-12-19 |
Arthritis (1) · Arthritis, Psoriatic (1) · Bursitis (1) · Giant Cell Tumor of Tendon Sheath (1) · Joint Diseases (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Synovitis, Pigmented Villonodular (1) · Tendinopathy (1)
Musculoskeletal Diseases (4) · Joint Diseases (3) · Muscular Diseases (2) · Arthritis (1) · Bone Diseases (1) · Giant Cell Tumors (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Psoriasis (1) · Rheumatic Diseases (1) · Skin Diseases (1) · Skin Diseases, Papulosquamous (1) · Skin and Connective Tissue Diseases (1)
Betamethasone (1) · Chondroitin (1) · Etoricoxib (1) · pexidartinib (1) · secukinumab (1)
Bioiberica (1) · Daiichi Sankyo (1) · Laboratorios Silanes S.A. de C.V. (1) · Novartis Pharmaceuticals (1)
Canada (3) · France (2) · Germany (2) · Hungary (2) · Italy (2) · Mexico (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Colombia (1)
Jean-Pierre Pelletier, Prof., Dr. (1) · Johanne Martel-Pelletier, Prof., Dr. (1) · Juan Luis Torres Mendez, MD (1) · Marco Antonio Cordova Martinez, MD (1) · Pedro Abraham Garza Alvarez, MD (1) · Yazmin Adriana Guerra Lopez, MD (1)
PMID 21367761, PMID 27041409, PMID 31229240, PMID 32755241, PMID 33289960, PMID 34528079, PMID 36001000, PMID 41612350, PMID 42132251
2014 (1), 2015 (1)